Therapy Areas: Cardiovascular
Daiichi Sankyo secures EMA validation for two triple-combination cholesterol therapies
29 October 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Thursday that it has received European Medicines Agency (EMA) validation for two marketing authorisation app...
Ascletis reports positive US Phase II topline results for ASC30 in diabetes
29 October 2026 - Chinese pharmaceutical company Ascletis Pharma Inc (HKEX:1672) on Wednesday reported positive topline results from its US Phase II study evaluating ASC30, an oral small molecule GLP-...
Edwards Lifesciences wins FDA approval for PASCAL Precision tricuspid repair system
21 October 2026 - Edwards Lifesciences Corporation (NYSE: EW), a structural heart innovation company, announced on Wednesday that it has received US Food and Drug Administration (FDA) approval for its...
Oracle partners AstraZeneca for AI-enabled healthcare innovation
20 October 2026 - US-based tech firm Oracle Corporation (NYSE: ORCL) announced on Tuesday an agreement with UK-based pharmaceutical company AstraZeneca (LON: AZN) to explore how AI and real-world data...
Medtronic confirms separation of MiniMed
16 October 2026 - Healthcare technology company Medtronic plc (NYSE:MDT) announced on Thursday that it has completed its separation of MiniMed Group Inc (Nasdaq:MMED).Medtronic elected to exchange all...
Philips-led EXIT-CVD consortium launches cardiovascular clinical studies across Europe
15 October 2026 - Dutch health technology company Royal Philips (NYSE:PHG) (AEX:PHIA) on Thursday announced the launch of EXIT-CVD, a five-year research initiative led by Philips and University Medica...